H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 42 Citations 6,251 104 World Ranking 3076 National Ranking 1241

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Antibiotics
  • Tuberculosis

Tuberculosis, Internal medicine, Immunology, Mycobacterium tuberculosis and Antibacterial agent are his primary areas of study. His biological study spans a wide range of topics, including Regimen, Respiratory disease and Randomized controlled trial. His work carried out in the field of Internal medicine brings together such families of science as Pyrazinamide, Rifampicin, Isoniazid, Surgery and Gastroenterology.

The study incorporates disciplines such as Retrospective cohort study, Acquired immunodeficiency syndrome and Cohort study in addition to Immunology. His Mycobacterium tuberculosis research is multidisciplinary, incorporating elements of Interleukin and Disease. The various areas that John L. Johnson examines in his Antibacterial agent study include Moxifloxacin, Pharmacokinetics, Pharmacology and Intensive care.

His most cited work include:

  • A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus (353 citations)
  • Depressed T-Cell Interferon-γ Responses in Pulmonary Tuberculosis: Analysis of Underlying Mechanisms and Modulation with Therapy (267 citations)
  • Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. (246 citations)

What are the main themes of his work throughout his whole career to date?

John L. Johnson mainly focuses on Tuberculosis, Internal medicine, Immunology, Mycobacterium tuberculosis and Sputum. His Tuberculosis research focuses on Clinical trial and how it connects with Drug. His studies in Internal medicine integrate themes in fields like Gastroenterology, Pyrazinamide, Rifampicin and Surgery.

In his study, which falls under the umbrella issue of Immunology, Latent tuberculosis is strongly linked to Virology. John L. Johnson has researched Mycobacterium tuberculosis in several fields, including Respiratory disease, Microbiology and Vaccination. In his study, Pharmacokinetics is strongly linked to Antibiotics, which falls under the umbrella field of Sputum.

He most often published in these fields:

  • Tuberculosis (63.02%)
  • Internal medicine (41.67%)
  • Immunology (34.90%)

What were the highlights of his more recent work (between 2012-2021)?

  • Tuberculosis (63.02%)
  • Internal medicine (41.67%)
  • Mycobacterium tuberculosis (30.73%)

In recent papers he was focusing on the following fields of study:

John L. Johnson mainly investigates Tuberculosis, Internal medicine, Mycobacterium tuberculosis, Immunology and Sputum. His study in Tuberculosis is interdisciplinary in nature, drawing from both Clinical trial, Young adult, Regimen, Disease and Prospective cohort study. He interconnects Surgery, Ethambutol and Drug in the investigation of issues within Internal medicine.

His studies deal with areas such as Gastroenterology, T cell, Coinfection and Isoniazid as well as Mycobacterium tuberculosis. His work on Vaccination, CD8 and Inflammation as part of general Immunology study is frequently connected to Biomarker discovery, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Sputum study incorporates themes from Mycobacterium tuberculosis complex and Agar.

Between 2012 and 2021, his most popular works were:

  • A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis. (91 citations)
  • A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis. (91 citations)
  • Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. (91 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Antibiotics
  • Tuberculosis

John L. Johnson mostly deals with Tuberculosis, Internal medicine, Immunology, Mycobacterium tuberculosis and Randomized controlled trial. His research in Tuberculosis is mostly concerned with Isoniazid. His Internal medicine research incorporates elements of Sputum and Surgery.

His Immunology study integrates concerns from other disciplines, such as Prospective cohort study and Disease. His Mycobacterium tuberculosis research is multidisciplinary, relying on both CD8, Immune system and Vaccination. His Randomized controlled trial research includes themes of Infectious disease, Regimen, Drug resistance and Dosing.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus

Whalen Cc;Johnson Jl;Okwera A;Hom Dl.
The New England Journal of Medicine (1997)

554 Citations

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.

William J. Burman;Stefan Goldberg;John L. Johnson;Grace Muzanye.
American Journal of Respiratory and Critical Care Medicine (2006)

375 Citations

Depressed T-Cell Interferon-γ Responses in Pulmonary Tuberculosis: Analysis of Underlying Mechanisms and Modulation with Therapy

Christina S. Hirsch;Zahra Toossi;Catherine Othieno;John L Johnson.
The Journal of Infectious Diseases (1999)

362 Citations

Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis

John L. Johnson;D. J. Hadad;W. H. Boom;C. L. Daley.
International Journal of Tuberculosis and Lung Disease (2006)

325 Citations

Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis

Susan E. Dorman;John L. Johnson;Stefan Goldberg;Grace Muzanye.
American Journal of Respiratory and Critical Care Medicine (2009)

316 Citations

Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

Christopher C. Whalen;Peter Nsubuga;Alphonse Okwera;John L. Johnson.
AIDS (2000)

256 Citations

A study of the safety immunology virology and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis.

Robert S. Wallis;Peter Kyambadde;John L. Johnson;Libby Horter.
AIDS (2004)

253 Citations

Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary Tuberculosis

Charles A. Peloquin;David Jamil Hadad;Lucilia Pereira Dutra Molino;Moises Palaci.
Antimicrobial Agents and Chemotherapy (2008)

206 Citations

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.

John L. Johnson;Alphonse Okwera;David L. Hom;Harriet Mayanja.
AIDS (2001)

202 Citations

Infection and disease among household contacts of patients with multidrug-resistant tuberculosis.

L Teixeira;M D Perkins;J L Johnson;R Keller.
International Journal of Tuberculosis and Lung Disease (2001)

199 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing John L. Johnson

Robert J. Wilkinson

Robert J. Wilkinson

The Francis Crick Institute

Publications: 104

Gerhard Walzl

Gerhard Walzl

Stellenbosch University

Publications: 72

Robert S. Wallis

Robert S. Wallis

Aurum Institute

Publications: 57

Eric L. Nuermberger

Eric L. Nuermberger

Johns Hopkins University

Publications: 55

Alimuddin Zumla

Alimuddin Zumla

University College London

Publications: 54

Thomas J. Scriba

Thomas J. Scriba

University of Cape Town

Publications: 50

Jerrold J. Ellner

Jerrold J. Ellner

Rutgers, The State University of New Jersey

Publications: 48

Clifton E. Barry

Clifton E. Barry

National Institutes of Health

Publications: 48

Zahra Toossi

Zahra Toossi

Case Western Reserve University

Publications: 47

Gavin J. Churchyard

Gavin J. Churchyard

Aurum Institute

Publications: 41

Moses Joloba

Moses Joloba

Makerere University

Publications: 39

William R. Bishai

William R. Bishai

Johns Hopkins University

Publications: 37

Graeme Meintjes

Graeme Meintjes

University of Cape Town

Publications: 36

Richard E. Chaisson

Richard E. Chaisson

Johns Hopkins University

Publications: 34

Megan Murray

Megan Murray

Harvard University

Publications: 34

Keertan Dheda

Keertan Dheda

University of Cape Town

Publications: 33

Something went wrong. Please try again later.